Metformin and GLP-1 receptor agonists significantly reduce asthma attacks in patients with type 2 diabetes, offering ...

Treatment with metformin was associated with a reduction in asthma attacks among patients with asthma and type 2 diabetes, with additional reductions observed with the use of GLP-1 receptor agonists, ...

In addition, ICS-SABA and ICS-formoterol were associated with "modest" improvements in asthma control, without the risk of an increase in adverse events. "Anti-inflammatory relievers are superior to ...

“The results of this cohort study suggest that metformin was associated with a lower rate of asthma attacks, with further reductions with the use of GLP-1 RA,” the authors write. “This appeared to be ...